Non small cell lung cancer natural history: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


If left untreated, non-small cell lung cancer progression occurs slowly and is then followed by local invasion to [[lymph nodes]] and distant [[metastasis]]. Non-small cell lung cancer is a locally aggressive tumor, commonly occurs in patients in the fourth and sixth decade of life. Common sites of metastasis include [[adrenal gland]], [[Bone tumors|bone]], [[brain]], and [[liver]]. Complications of non-small cell lung cancer are usually related to the site of metastasis. The 5-year relative survival of patients with non-small cell lung cancer is approximately 50%. Features associated with worse prognosis are [[genetic markers]], tumor size, associated conditions, clinical fitness for surgery, presence of lymphatic invasion, location of lesion, presence of satellite lesions, and presence of regional or distant metastases.Prognosis is generally regarded as poor with an all-stage average survival rate of 50%.  The 5-year recurrence rate of non-small cell lung cancer is 24%.<ref name="pmid17356101">{{cite journal |vauthors=Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E |title=Prognosis of lung cancer patients with life-threatening complications |journal=Chest |volume=131 |issue=3 |pages=840–6 |year=2007 |pmid=17356101 |doi=10.1378/chest.06-2244 |url=}}</ref>
If left untreated, non-small cell lung cancer progression occurs slowly and is then followed by local invasion to [[lymph nodes]] and distant [[metastasis]].<ref name="pmid17356101">{{cite journal |vauthors=Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E |title=Prognosis of lung cancer patients with life-threatening complications |journal=Chest |volume=131 |issue=3 |pages=840–6 |year=2007 |pmid=17356101 |doi=10.1378/chest.06-2244 |url=}}</ref> Non-small cell lung cancer is a locally aggressive tumor, commonly occurs in patients in the fourth and sixth decade of life. Common sites of metastasis include [[adrenal gland]], [[Bone tumors|bone]], [[brain]], and [[liver]]. Complications of non-small cell lung cancer are usually related to the site of metastasis. The 5-year relative survival of patients with non-small cell lung cancer is approximately 50%. Features associated with worse prognosis are [[genetic markers]], tumor size, associated conditions, clinical fitness for surgery, presence of lymphatic invasion, location of lesion, presence of satellite lesions, and presence of regional or distant metastases.Prognosis is generally regarded as poor with an all-stage average survival rate of 50%.  The 5-year recurrence rate of non-small cell lung cancer is 24%.<ref name="pmid17356101">{{cite journal |vauthors=Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E |title=Prognosis of lung cancer patients with life-threatening complications |journal=Chest |volume=131 |issue=3 |pages=840–6 |year=2007 |pmid=17356101 |doi=10.1378/chest.06-2244 |url=}}</ref>


==Natural History==
==Natural History==
* Most patients with non-small cell lung cancer are initially asymptomatic.
* Most patients with non-small cell lung cancer are initially asymptomatic.<ref name="pmid17356101">{{cite journal |vauthors=Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E |title=Prognosis of lung cancer patients with life-threatening complications |journal=Chest |volume=131 |issue=3 |pages=840–6 |year=2007 |pmid=17356101 |doi=10.1378/chest.06-2244 |url=}}</ref>
* The symptoms of non-small cell lung cancer usually develop in the fourth and sixth decade of life.  
* The symptoms of non-small cell lung cancer usually develop in the fourth and sixth decade of life.  
* Initially patients complain of [[Cough|chronic cough]], [[diaphoresis]], and [[weight-loss]].  
* Initially patients complain of [[Cough|chronic cough]], [[diaphoresis]], and [[weight-loss]].  
Line 26: Line 26:
* Non-small cell lung cancer [[survival rate]] ranges from 1 to 52% (stage I to stage IV)  
* Non-small cell lung cancer [[survival rate]] ranges from 1 to 52% (stage I to stage IV)  
* The recurrence rate of non-small cell lung cancer is 24%
* The recurrence rate of non-small cell lung cancer is 24%
* The median survival time of non-small cell lung cancer after a complication, such as malignant pleural effusion is 1 to 3 months.  
* The median survival time of non-small cell lung cancer after a complication, such as malignant pleural effusion is 1 to 3 months.<ref name="pmid3183615">{{cite journal |vauthors=Phonimdaeng P, O'Reilly M, O'Toole PW, Foster TJ |title=Molecular cloning and expression of the coagulase gene of Staphylococcus aureus 8325-4 |journal=J. Gen. Microbiol. |volume=134 |issue=1 |pages=75–83 |year=1988 |pmid=3183615 |doi=10.1099/00221287-134-1-75 |url=}}</ref>
* The prognosis for malignant transformation of non-small cell lung cancer will depend on the histological grade
* The prognosis for malignant transformation of non-small cell lung cancer will depend on the histological grade
* The table below summarizes the 5-year survival rate according to non-small cell lung cancer stage:
* The table below summarizes the 5-year survival rate according to non-small cell lung cancer stage:

Revision as of 22:38, 23 February 2016

Non Small Cell Lung Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non Small Cell Lung Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Approach

Stage I
Stage II
Stage III
Stage IV
Metastatic Cancer

Medical Therapy

Chemotherapy
Radiation Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non small cell lung cancer natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non small cell lung cancer natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non small cell lung cancer natural history

CDC on Non small cell lung cancer natural history

Non small cell lung cancer natural history in the news

Blogs on Non small cell lung cancer natural history

Directions to Hospitals Treating Non small cell carcinoma of the lung

Risk calculators and risk factors for Non small cell lung cancer natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2] Maria Fernanda Villarreal, M.D. [3]

Overview

If left untreated, non-small cell lung cancer progression occurs slowly and is then followed by local invasion to lymph nodes and distant metastasis.[1] Non-small cell lung cancer is a locally aggressive tumor, commonly occurs in patients in the fourth and sixth decade of life. Common sites of metastasis include adrenal gland, bone, brain, and liver. Complications of non-small cell lung cancer are usually related to the site of metastasis. The 5-year relative survival of patients with non-small cell lung cancer is approximately 50%. Features associated with worse prognosis are genetic markers, tumor size, associated conditions, clinical fitness for surgery, presence of lymphatic invasion, location of lesion, presence of satellite lesions, and presence of regional or distant metastases.Prognosis is generally regarded as poor with an all-stage average survival rate of 50%. The 5-year recurrence rate of non-small cell lung cancer is 24%.[1]

Natural History

Complications

  • Common complications of non-small cell lung cancer, include:[1]

Prognosis

  • Non-small cell lung cancer prognosis and recurrence depends on the origin of primary tumor, histological type, and stage
  • Non-small cell lung cancer prognosis is generally regarded as poor
  • Non-small cell lung cancer survival rate ranges from 1 to 52% (stage I to stage IV)
  • The recurrence rate of non-small cell lung cancer is 24%
  • The median survival time of non-small cell lung cancer after a complication, such as malignant pleural effusion is 1 to 3 months.[2]
  • The prognosis for malignant transformation of non-small cell lung cancer will depend on the histological grade
  • The table below summarizes the 5-year survival rate according to non-small cell lung cancer stage:
Stage 5-year survival rate
IA 49%
IB 45%
IIA 30%
IIB 31%
IIIA 14%
IIIB 5%
IV 1%

References

  1. 1.0 1.1 1.2 1.3 Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E (2007). "Prognosis of lung cancer patients with life-threatening complications". Chest. 131 (3): 840–6. doi:10.1378/chest.06-2244. PMID 17356101.
  2. Phonimdaeng P, O'Reilly M, O'Toole PW, Foster TJ (1988). "Molecular cloning and expression of the coagulase gene of Staphylococcus aureus 8325-4". J. Gen. Microbiol. 134 (1): 75–83. doi:10.1099/00221287-134-1-75. PMID 3183615.


Template:WikiDoc Sources